Pfizer – Optimizing Canadian Telehealth Use for Women’s Health

NEW DEADLINE: February 20, 2023

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Additional information can be found here.

Geographic Scope: Canada

Clinical Area: Women’s Health

Link to full RFP: Optimizing Canadian Telehealth Use for Women’s Health

Application Due Date: February 13, 2023

Specific Area of Interest: It is our intent to support Quality Improvement initiatives that enhance the women’s health virtual quality of care by focusing on equity and appropriateness of virtual care.